Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From natural products to HDAC inhibitors: An overview of drug discovery and design strategy
Xiang Qiu, Lv Zhu, Huan Wang, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 52, pp. 116510-116510
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies
Pritee Chunarkar Patil, Mohammed Kaleem, Richa Mishra, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 201-201
Open Access | Times Cited: 69
Synthesis, reactions and application of chalcones: a systematic review
Mona A. Shalaby, Sameh A. Rizk, Asmaa M. Fahim
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 26, pp. 5317-5346
Closed Access | Times Cited: 44
Macrocycles and macrocyclization in anticancer drug discovery: Important pieces of the puzzle
Chao Zhang, Fenfen Liu, You‐Ming Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116234-116234
Closed Access | Times Cited: 18
The green chemistry paradigm in modern organic synthesis
Sergei G. Zlotin, Ksenia S. Egorova, Valentine P. Ananikov, et al.
Russian Chemical Reviews (2023) Vol. 92, Iss. 12, pp. RCR5104-RCR5104
Closed Access | Times Cited: 33
Recent Advances in Search of Bioactive Secondary Metabolites from Fungi Triggered by Chemical Epigenetic Modifiers
Mengyao Xue, Xuwen Hou, Jiajin Fu, et al.
Journal of Fungi (2023) Vol. 9, Iss. 2, pp. 172-172
Open Access | Times Cited: 28
Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
Sk. Abdul Amin, Samima Khatun, Shovanlal Gayen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115594-115594
Closed Access | Times Cited: 17
Challenges and opportunities for improving the druggability of natural product: Why need drug delivery system?
Peng Tang, Tianze Shen, Hairong Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114955-114955
Open Access | Times Cited: 15
Challenges in natural product-based drug discovery assisted within silico-based methods
Conrad V. Simoben, Smith B. Babiaka, Aurélien F. A. Moumbock, et al.
RSC Advances (2023) Vol. 13, Iss. 45, pp. 31578-31594
Open Access | Times Cited: 15
A perspective on the application of macrocyclic design strategies in antitumor drugs
Yanhong Li, Yukang Lin, Junjie Cai, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108190-108190
Closed Access
Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment
Feifei Yang, Ting Hu, Jianquan Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114920-114920
Closed Access | Times Cited: 15
Exploring the potential of epigenetic chemicals to increase metabolite production in the dinoflagellate microalga Amphidinium carterae
S. Kichouh-Aiadi, Juan José Gallardo, M.C. Cerón-García, et al.
Journal of Applied Phycology (2024) Vol. 36, Iss. 3, pp. 1169-1179
Open Access | Times Cited: 2
Total Synthesis of the Naturally Occurring Cyclic Tetrapeptide JM‐47 and Analogues through Late‐Stage Functionalization of a Common Scaffold
Rajat Ghosh, Shital K. Chattopadhyay
European Journal of Organic Chemistry (2024) Vol. 27, Iss. 22
Closed Access | Times Cited: 2
Progress in the discovery and development of anticancer agents from marine cyanobacteria
Hendrik Luesch, Emma K. Ellis, Qi-Yin Chen, et al.
Natural Product Reports (2024)
Open Access | Times Cited: 2
Trichodermin inhibits the growth of oral cancer through apoptosis-induced mitochondrial dysfunction and HDAC-2-mediated signaling
Hsien-Lin Chen, Yi-Hao Lo, Chieh-Liang Lin, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113351-113351
Open Access | Times Cited: 10
Discovery of novel polysubstituted N -alkyl acridone analogues as histone deacetylase isoform-selective inhibitors for cancer therapy
Ze Wang, Zhao Li, Bo Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
Coumarin-derived Hydroxamic Acids as Histone Deacetylase Inhibitors: A Review of Anti-cancer Activities
Nguyen Quang Khai, Tran Khac Vu
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 18-29
Closed Access | Times Cited: 5
Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity
Qian Zhao, Shan-Shan Xiong, Can Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Identification of structural fingerprints among natural inhibitors of HDAC1 to accelerate nature-inspired drug discovery in cancer epigenetics
Sourav Sardar, Jyotisha, Sk. Abdul Amin, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 11, pp. 5642-5656
Closed Access | Times Cited: 3
Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents
Abhishek Wahi, Priti Jain, Apurba Sinhari, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023)
Closed Access | Times Cited: 3
Research on the progress of Traditional Chinese medicine components and preparations on histone deacetylase inhibitors - Like effects in the course of disease treatment
Yuxin Wei, Yuyan Guo, Shaowa Lv
Journal of Ethnopharmacology (2022) Vol. 296, pp. 115521-115521
Closed Access | Times Cited: 5
Histone deacetylase inhibitors regulate the oral cancer via PI3K/AKT signaling pathway
Mydhili Govindarasu, Lavanya Prathap, Rajakumar Govindasamy
Oral Oncology (2022) Vol. 135, pp. 106221-106221
Closed Access | Times Cited: 4
Therapeutic Strategies for Angiogenesis Based on Endothelial Cell Epigenetics
Yue Cai, Lihua Li, Chen Shao, et al.
Journal of Cardiovascular Translational Research (2024) Vol. 17, Iss. 4, pp. 816-827
Closed Access
Synthesis and histone deacetylases inhibitory activity of pyrimidine‐based 1,3,4‐oxadiazoles
Virginija Jakubkienė, I. Labalaukyte, Markus Schweipert, et al.
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 9, pp. 1426-1438
Closed Access
Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer
Xiaohong Chen, Xia Ding, Jiebin Fang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 14609-14632
Closed Access
Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired N-Linked 2-Acetylpyrrole Cap
Han Zhang, Qianqian Shen, Hu Zhu, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4653-4653
Open Access
Page 1 - Next Page

Scroll to top